Anxiety

An umbrella review published in The BMJ provided a breakdown of the associations between cannabis and health outcomes, highlighting the uncertain potential for clinical use.

SAN DIEGO — Psilocybin has emerged as a potential treatment for depression and anxiety, including among patients with chronic rheumatic or autoimmune conditions, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

PHILADELPHIA — Patients with a psychotic-spectrum disorder may be more likely to develop Parkinson’s disease, especially if they have an additional diagnosis of anxiety, according to a poster presentation.

Transgender and gender-diverse adolescents reported high menstrual suppression effectiveness and satisfaction, according to a cross-sectional study published in Obstetrics & Gynecology.

An audiovisual-stimulation device improved fibromyalgia symptoms and decreased the use of medications and health care services, according to results of a pilot study presented at PAINWeek.

Many users of a smartphone-based CV risk management system who had severe anxiety at baseline had improved anxiety symptoms over time, likely driven by reductions in BP and heart rate, researchers reported.

In patients with symptomatic atrial fibrillation, catheter ablation improved psychological symptoms of anxiety and depression compared with medical therapy, according to results of the REMEDIAL trial.

The impact of COVID-19 extends beyond those who get infected and evokes symptoms of anxiety, depression and PTSD in their families, according to two studies published in Annals of the American Thoracic Society.

Psychological therapies provided short-term improvements in anxiety, depression, stress and quality of life in people with quiescent inflammatory bowel disease but did not improve disease activity or prevent relapse, according to analysis.

Psychological distress may be linked to poor self-management of chronic kidney disease, according to a recently published study of patients with CKD who were not on dialysis.